Provided by Tiger Trade Technology Pte. Ltd.

Illumina

117.67
-6.7300-5.41%
Post-market: 117.00-0.6700-0.57%19:53 EDT
Volume:1.22M
Turnover:144.75M
Market Cap:17.98B
PE:21.59
High:123.32
Open:123.00
Low:116.74
Close:124.40
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.83
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:6.60
PE(LYR):21.59

Loading ...

24H | Brighthouse Surges 19%; Illumina Jumps 7%; Lumen Gains 6%; Riot Rises 5%; Roku Sinks 5%

Tiger Newspress
·
Oct 31, 2025

Stock Track | Illumina Soars 7.05% on Strong Q3 Results and Raised Full-Year Guidance

Stock Track
·
Oct 31, 2025

Stock Track | Illumina Soars 7.05% After Smashing Q3 Earnings Expectations and Raising 2025 Guidance

Stock Track
·
Oct 31, 2025

Stock Track | Illumina Soars 5.09% After-Hours on Strong Q3 Results, Raised Guidance

Stock Track
·
Oct 31, 2025

Genomics company Illumina Q3 revenue beats expectations, helped by clinical market growth

Reuters
·
Oct 31, 2025

Illumina Q3 Adj. EPS $1.34 Beats $1.17 Estimate, Sales $1.084B Beat $1.065B Estimate

Benzinga
·
Oct 31, 2025

Illumina Q3 Adjusted EBIT Margin 24.5%

THOMSON REUTERS
·
Oct 31, 2025

Illumina Outlook FY Adjusted EPS USD 4.65-4.75

THOMSON REUTERS
·
Oct 31, 2025

Illumina Q3 EBIT Margin 21%

THOMSON REUTERS
·
Oct 31, 2025

Illumina’s Sequencing Study: A Game Changer in Hematologic Diagnostics?

TIPRANKS
·
Oct 28, 2025

10x sues rival Illumina over gene-sequencing patents

Reuters
·
Oct 22, 2025

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades'

Benzinga_recent_news
·
Oct 21, 2025

Has Illumina’s Rally After Grail Divestiture Put Its Valuation Back on Track?

Simply Wall St.
·
Oct 21, 2025

Illumina Faces Competitive Threat from Roche’s SBX Platform: Analyst Issues Sell Rating

TIPRANKS
·
Oct 20, 2025

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

prnewswire
·
Oct 17, 2025

Roche Sets Gene-Sequencing Record. It's a Challenge for Illumina. -- Barrons.com

Dow Jones
·
Oct 17, 2025

Stock Track | Illumina Stock Soars 5.05% on Launch of Revolutionary 5-Base Solution for Genomic Research

Stock Track
·
Oct 16, 2025

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Illumina (ILMN)

TIPRANKS
·
Oct 16, 2025

Stock Track | Illumina Soars 5.04% on Breakthrough Technologies and AI Healthcare Potential

Stock Track
·
Oct 15, 2025

Stock Track | Illumina Soars 5.04% on Breakthrough Technologies and AI Potential in Healthcare

Stock Track
·
Oct 15, 2025